Dyslexia Treatment Market Share, Trends And Growth By 2034

Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence

How Has the Dyslexia Treatment Market Evolved in Terms of Size and Value From 2025 to 2029?
The dyslexia treatment market size has grown strongly in recent years. It will grow from $28.19 billion in 2024 to $30.17 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to global collaboration and sharing of best practices, shifting societal attitudes towards learning disabilities, adoption of comprehensive treatment plans that incorporate psychological, educational, and medical interventions, enhanced funding from government and private sectors for research and educational programs, implementation of laws and regulations mandating support for students with learning disabilities.

The dyslexia treatment market size is expected to see strong growth in the next few years. It will grow to " $38.86 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growing awareness about dyslexia among parents, implementation of inclusive education policies and specialized educational programs for dyslexic students, an increase in the diagnosed cases of dyslexia, continuous training and development programs for educators and therapists, the rise of telehealth and online therapy services. Major trends in the forecast period include artificial intelligence tools for early diagnosis and customized treatment plans, the use of software-based interventions, the use of real-time brain activity monitoring to help individuals improve their reading skills, advanced speech-to-text applications to aid in reading and writing for dyslexic users, demand for devices that monitor cognitive functions and provide feedback to support learning and concentration.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16402&type=smp

Which Key Drivers Are Fueling Growth in the Dyslexia Treatment Market?
An increase in the prevalence of neurological disorders is expected to propel the growth of the dyslexia treatment market going forward. Neurological disorders are medical conditions that affect the nervous system, including the brain, spinal cord, and nerves. The prevalence of neurological disorders is increasing due to factors such as an aging population, lifestyle changes, environmental factors, and improved diagnostic techniques that lead to better detection and reporting of these conditions. Dyslexia treatments, such as multisensory learning and cognitive training, show the potential to improve neurological disorders by enhancing brain plasticity and cognitive functions. For instance, in March 2024, according to the according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 3 billion people globally were living with a neurological condition. Additionally, over 80% of deaths and health losses due to neurological conditions occur in low- and middle-income countries. Access to treatment varies significantly, with high-income countries having up to 70 times more neurological professionals per 100,000 people than low- and middle-income countries. Therefore, an increase in the prevalence of neurological disorders is driving the growth of the dyslexia treatment market.

What Are the Major Segments Defining the Structure of the Dyslexia Treatment Market?
The dyslexia treatmentmarket covered in this report is segmented –

1) By Type: Double Deficit Dyslexia; Visual Dyslexia; Phonological Dyslexia; Other Types
2) By Therapy: Occupational Therapy; Speech Therapy; Cognitive Behavioral Therapy
3) By Drugs: Cyclizine; Meclizine; Dimenhydrinate; Methylphenidate; Other Drugs
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
5) By End Users: Psychiatric Institutions; Rehabilitation Centers; Home Care; Other End-users

Subsegments:
1) By Double Deficit Dyslexia: Phonological And Visual Processing Treatment; Integrated Therapy Approaches
2) By Visual Dyslexia: Visual Processing Treatment; Optometric And Visual Therapy; Color Overlay Therapy
3) By Phonological Dyslexia: Phonics-Based Treatment; Speech And Language Therapy; Auditory Training And Exercises
4) By Other Types: Rapid Naming Dyslexia; Motor Dyslexia; Surface Dyslexia

Which Major Trends Are Expected to Define the Dyslexia Treatment Market Through 2029?
Major companies operating in the dyslexia treatment market are focusing on developing advanced solutions, such as white noise feature, to better serve customers. The white noise feature is an auditory tool designed to enhance focus, concentration, and reading fluency, especially for neurodivergent learners, such as those with ADHD, by providing consistent sound. For instance, in October 2024, Promova Limited, a US-based technology company, launched Dyslexia Mode 2.0. Which is an enhanced feature designed to make language learning more accessible for individuals with dyslexia and other neurodiverse conditions. Expanding on the original Dyslexia Mode, it introduces improvements like adjustable font sizes, color shifting to soften contrasts, and the removal of all-caps text to enhance readability. These updates aim to reduce visual stress and provide a more comfortable learning experience for neurodivergent users. Developed with insights from experts such as dyslexic designer Martin Pysny, Dyslexia Mode 2.0 strives to create an inclusive, user-friendly environment, improving language learning for individuals with unique learning challenges.

Which Key Players Dominate the Dyslexia Treatment Market Landscape?
Major companies operating in the dyslexia treatment market are Pfizer Inc., AstraZeneca Plc, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma, Apotex Corporation, Endo International Plc, Amneal Pharmaceuticals LLC, Unither Pharmaceuticals LLC, RPG Life Sciences Ltd., Jubilant Pharma Limited, Breckenridge Pharmaceutical Inc., Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd, Lexia Learning Systems LLC, Wallace Pharmaceuticals Ltd., Ironshore Pharmaceuticals Inc., DK Pharmachem Pvt Ltd., Speechify Inc., Lingit AS, Lyfta, Nessy Learning Ltd.

Get the detailed dyslexia treatment market report today
https://www.thebusinessresearchcompany.com/report/dyslexia-treatment-global-market-report

Which Region Is Expected to Dominate the Dyslexia Treatment Market During the Forecast Period?
North America was the largest region in the dyslexia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dyslexia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company